Diabetes Mellitus, Type 2
Conditions
Brief summary
The investigators will examine the influence of increasing motivation on healthy lifestyle and glycemic control in diabetes patients. Participants will be randomized to two groups, the control group gets informational text message and the intervention group gets motivational SMS. The patients get a weekly text message and after 26 weeks the HbA1c and quality of life will be assessed.
Detailed description
The investigators will examine the influence of increasing motivation on healthy lifestyle and glycemic control in diabetes patients. Participants will provide demographic and clinical information, fill human value questionnaires and quality of life questionnaires and decide on personal lifestyle-improvement goals. They will then be randomized to one of two groups: the control group gets informational text message and the intervention group gets motivational text message. The patients get a weekly text message and after 26 weeks we will check the HbA1c and quality of life. The text message will be personalized by including personal details acquired by a questionnaire. They will provide demographic and clinical information. In addition, the influence of demographic characters and related DM character on the benefit of the motivational SMS will be assessed.
Interventions
BEHAVIORALmotivational SMS
the participant receives a weekly text message that is aimed to increase motivation
BEHAVIORALinformational SMS
the participant a weekly text message that is provides information on improving lifestyle
Sponsors
Rambam Health Care Campus
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
TRIPLE (Subject, Caregiver, Investigator)
Masking description
Randomization will be by study personell that is not in contact with participants
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Uncontrolled DM 2 patients (HbA1c \> 8%) * Know to read (Hebrew or Arabic) * Have a cellular phone * Can sign informed consent.
Exclusion criteria
* A life expectancy of less than one year
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HbA1c levels at 6 months from beginning of messages | at 6 months from beginning of study | Blood HbA1c levels are reflective of how well diabetes is controlled |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Diabetes Quality of Life questionnaire | at 6 months from beginning of study | To design and test the reliability and validity of a brief treatment |
Countries
Israel
Contacts
Primary ContactIrit Hochberg, MD/PhD
Outcome results
None listed